Lallemand Health Solutions’ probiotic production facilities receive GMP certification

d0500572-f626-4557-867c-910ff9d14fd0articleimage.jpg

08 Sep 2017 --- Lallemand Health Solutions in Canada is breaking new ground in probiotic production quality standards as both of its plants in Montreal and Mirabel have successfully passed the United States Pharmacopeia (USP) Quality Systems Good Manufacturing Practice (GMP) audit, becoming the first probiotic production facilities to receive this quality certificate.

“Such achievement illustrates our long-standing commitment to quality and demonstrates the level of our quality systems,” says Francine Mondou, President of Lallemand Health Solutions.

“For our customers, this helps provide them with assurance in the quality of our probiotic production operation. It also represents a stepping stone for those willing to get their finished product compliant with the USP verified program.”

“USP is the most authoritative source for dietary supplement GMP audits. USP’s GMP audit program serves dietary supplement and dietary ingredient manufacturers. It provides assurance that dietary supplement manufacturers not only meet FDA cGMPs but exceed them, as it is the only program that requires manufacturers to comply with both FDA and USP GMPs.”

USP GMPs include requirements of particular interest to retailers such as recall procedures, expiration dating supported by stability data for instance, explains John Atwater, Senior Director of Verification Services for USP.   

“This is the first time a probiotic production facility’s GMP quality systems have been verified by USP, and this can facilitate the task for the companies wanting to participate in USP verified program for their finished products, as more and more dietary supplement companies are interested in doing so”, he says.

Solange Henoud, Regulatory Affairs Director at Lallemand Health Solutions further commented: “In practice, this means that USP’s audit found that Lallemand’s quality system provided sufficient assurance that its two Canadian manufacturing sites met applicable FDA and USP GMP audit requirements. With the reputation of USP, we are confident that this will facilitate recognition by regulatory authorities beyond borders.”

RELATED ARTICLES
Homepicture

Fibers and proteins among Naturex’s expansion and diversification strategy

24 Nov 2017 Over the past months, Naturex has moved to boost ...

Homepicture

A&B achieves probiotic patent for treatment of chronic digestive diseases

22 Nov 2017 A&B Ingredients’ probiotic PA5051 has ...

Homepicture

Gelita symposium paves a creative pathway to the future of food

21 Nov 2017 Nearly 80 delegates from a host of leading Food ...